US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BIOCARDIA INC

0.0061

0.0000

Volume:- -

Turnover:- -

Market Cap:41.02K

PE:0.00

High:0.0061

Open:0.0061

Low:0.0061

Close:0.0061

52wk High:0.0061

52wk Low:0.0061

Shares:6.73M

Float Shares:3.13M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.1995

EPS(LYR):-3.2801

ROE:-829.13%

ROA:-176.83%

PB:0.05

PE(LYR):0.00

Loading ...

Overview Company News Filings

Company Profile

Company Name:

BIOCARDIA INC

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.biocardia.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BCDAW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BCDAW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDAW\",,,,,undefined,":{"symbol":"BCDAW","market":"US","secType":"STK","nameCN":"BIOCARDIA INC","latestPrice":0.0061,"timestamp":1756497600000,"preClose":0.0061,"halted":0,"volume":0,"delay":0,"floatShares":3133364,"shares":6725025,"eps":-3.199549,"marketStatus":"Market Closed","change":0,"latestTime":"08-29 16:00:00 EDT","open":0.0061,"high":0.0061,"low":0.0061,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.199549,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1756800000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0061,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDAW\",,,,,undefined,":{"symbol":"BCDAW","floatShares":3133364,"roa":"-176.83%","roe":"-829.13%","lyrEps":-3.280116,"shares":6725025,"dividePrice":0,"high":0.0061,"amplitude":0,"preClose":0.0061,"low":0.0061,"week52Low":0.0061,"pbRate":"0.05","week52High":0.0061,"institutionHeld":0.0108,"latestPrice":0.0061,"eps":-3.199549,"divideRate":0,"volume":0,"delay":0,"ttmEps":-3.199549,"open":0.0061,"prevYearClose":0.0061,"prevWeekClose":0.0061,"prevMonthClose":0.0061,"prevQuarterClose":0.0061,"fiveDayClose":0.0061,"twentyDayClose":0.0061,"sixtyDayClose":0.0061},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCDAW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-11","symbol":"BCDAW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-08-05","symbol":"BCDAW","reason":null,"defaultRemindTime":1722864600000,"announcedDate":"2024-08-02","type":"delisting","dateTimestamp":1722830400000},{"market":"US","date":"2022-08-10","symbol":"BCDAW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1660104000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-05-11","symbol":"BCDAW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1652241600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-03-29","symbol":"BCDAW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1648526400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCDAW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCDAW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.biocardia.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":0.0167},{"period":"3month","weight":0.0944},{"period":"6month","weight":0.0856},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1006}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.100658},{"month":2,"riseRate":0.5,"avgChangeRate":0.250901},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.135831},{"month":4,"riseRate":0.5,"avgChangeRate":0.079462},{"month":5,"riseRate":0.5,"avgChangeRate":-0.016368},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.073415},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.250249},{"month":8,"riseRate":0.5,"avgChangeRate":0.106085},{"month":9,"riseRate":0.666667,"avgChangeRate":0.322976},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.099259},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.017922},{"month":12,"riseRate":0.5,"avgChangeRate":-0.04469}],"exchange":"NASDAQ","name":"BIOCARDIA INC","nameEN":"BIOCARDIA INC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BCDAW\",market:\"US\",,,undefined,":null}}